Skip to main content

Advertisement

Log in

Interferon free antiviral treatment of chronic hepatitis C in patients affected by β-thalassemia major

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Di Marco V, Capra M, Gagliardotto F, Borsellino Z, Cabibi D, Barbaria F et al (2008) Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. Haematologica 93(8):1243–1246

    Article  PubMed  Google Scholar 

  2. Gollo G, Savioli G, Balocco M, Venturino C, Boeri E, Costantini M, Forni GL (2013) Changes in the quality of life of people with thalassemia major between 2001 and 2009. Patient Prefer Adherence 7:231–236

    PubMed  PubMed Central  Google Scholar 

  3. Dhirar N, Khandekar J, Bachani D, Mahto D (2016) Thalassemia major: how do we improve quality of life? Spring 5(1):1895

    Article  Google Scholar 

  4. Di Marco V, Capra M, Angelucci E, Borgna-Pignatti C, Telfer P, Harmatz P et al (2010) Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel. Blood 116(16):2875–2883

    Article  CAS  PubMed  Google Scholar 

  5. Asselah T, Boyer N, Saadoun D, Martinot-Peignoux M, Marcellin P (2016) Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives. Liver Int 36:47–57

    Article  PubMed  Google Scholar 

  6. Talavera Pons S, Boyer A, Lamblin G, Chennell P, Châtenet F-T, Nicolas C et al (2017) Managing drug-drug interactions with new direct-acting antiviral agents in chronic hepatitis C. Br J Clin Pharmacol 83(2):269–293

  7. Fraquelli M, Cassinerio E, Roghi A, Rigamonti C, Casazza G, Colombo M et al (2010) Transient elastography in the assessment of liver fibrosis in adult thalassemia patients. Am J Hematol 85(8):564–568

    Article  CAS  PubMed  Google Scholar 

  8. Bachofner JA, Valli PV, Kröger A, Bergamin I, Künzler P, Baserga A et al (2017) Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index. Liver Int 37(3):369–376

  9. Spiegel BM, Younossi ZM, Hays RD, Revicki D, Robbins S, Kanwal F (2005) Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology 41(4):790–800

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elisa Biliotti.

Ethics declarations

Conflict of interest

Gloria Taliani has received advisory board and speaking fees from AbbVie, BMS, MSD, Roche, Janssen and Gilead. The other authors have nothing to disclose regarding funding or conflict of interest with respect to this manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Biliotti, E., Palazzo, D., Serani, M. et al. Interferon free antiviral treatment of chronic hepatitis C in patients affected by β-thalassemia major. Ann Hematol 96, 1043–1045 (2017). https://doi.org/10.1007/s00277-017-2986-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-017-2986-x

Keywords

Navigation